Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: Other
Life Threatening? No
Write-up: Information has been received from Sanofi Pasteur MSD (MFR Control Number 2016006998) on 05-JUL-2016, as a part of business agreement. This case was received from RA (Ref no. IE-HPRA-2016-027114) on 01-JUL-2016. Initial case received from a consumer/other non-health professional which concerns a 13-year-old female adolescent patient received GARDASIL (batch number G00566) on 26-MAR-2012, GARDASIL (batch number G00566) on 26-SEP-2011. The patient received concomitant administration of Insulin (Generic) on an unknown date. The patient experienced extreme/chronic fatigue, joint pain, headache, nausea, unexplained recurring viral infections, menstrual problems and feels unwell on an unknown date. The patient had a medical history of: Scoliosis, Type 1 diabetes mellitus. Corrective treatment to date: Complete rest, pain relief and antibiotic for throat, ear and chest infections. No treatment for viral infections. The patient''s outcome was reported as Not Recovered/Not Resolved. The reporter assessed the causal relationship: between Fatigue extreme, Joint pain, Headache, Nausea, Viral infection, Menstrual disorder, Feeling unwell and GARDASIL as Unknown.
Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166